Philip R. Debruyne

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

Benoit Beuselinck, Pascal Wolter, Alexandra Karadimou et al. · British Journal of Cancer · 2012 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17

Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life

Lies Pottel, Michelle Lycke, Tom Boterberg et al. · European Journal of Cancer Care · 2014 · 98 citations

Medicine, Oncology, Radiation Oncology +15

Bile Acids Induce Ectopic Expression of Intestinal Guanylyl Cyclase C Through Nuclear Factor-κB and Cdx2 in Human Esophageal Cells

Philip R. Debruyne, Matthew E. Witek, Li Gong et al. · Gastroenterology · 2006 · 91 citations · Full text

Medicine, Cell Biology, Molecular Biology +16

G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy

Lies Pottel, Michelle Lycke, Tom Boterberg et al. · BMC Cancer · 2015 · 87 citations · Full text

Medicine, Oncology, Radiation Oncology +17